v3.23.2
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development, net of grants $ 3,864 $ 3,203 $ 7,819 $ 5,883
General and administrative 3,139 884 5,785 2,112
Total operating expenses 7,003 4,087 13,604 7,995
Loss from operations (7,003) (4,087) (13,604) (7,995)
Other income (expense), net 477 (16) 760 (33)
Net income/(loss) $ (6,526) $ (4,103) $ (12,844) $ (8,028)
Net income/(loss) per common share – basic $ (0.13) $ (0.11) $ (0.25) $ (0.22)
Weighted average common shares outstanding – basic 50,795 36,880 50,748 36,819

Source